Literature DB >> 9350290

Interferon-gamma production in antigen specific T cell response: quantitation of specific mRNA and secreted protein.

M Halminen1, P Klemetti, O Vaarala, M Hurme, J Ilonen.   

Abstract

Interferon gamma (IFN-gamma) production as a measure of cellular sensitization was studied by detection of the cytokine in culture supernatant by enzyme immunoassay (EIA) and by measuring cellular mRNA using the reverse transcriptase polymerase chain reaction (RT-PCR) method. These assays were compared to the standard lymphocyte proliferation assay as a marker of T cell responsiveness to foreign antigens. When blood donors seropositive for herpes simplex virus (HSV) were compared to seronegative donors, all measurements of cellular sensitization separated the groups without overlap. There were significant correlations between the IFN-gamma mRNA titre and the secreted IFN-gamma (r = 0.57, P = 0.03), and the proliferative response and the secreted IFN-gamma (r = 0.78, P = 0.001), as well as between the IFN-gamma mRNA titre and the proliferative response (r = 0.78, P < 0.001). When tetanus toxoid (TT) responses were studied in immunized subjects, a wide range of responsiveness could be seen and correlation between various measurements was poor. However, constant individual levels of the cytokine production were demonstrated. Six people who had received their last TT booster vaccination more than 5 years ago were revaccinated and repeatedly studied. An increase in the levels of produced IFN-gamma could be seen in all subjects and two who lacked a lymphocyte proliferation response developed it after revaccination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350290     DOI: 10.1046/j.1365-3083.1997.d01-144.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  6 in total

1.  New means to monitor the effect of glucocorticoid therapy in children.

Authors:  Hanne Rintamäki; Harri M Salo; Outi Vaarala; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

2.  Serum immune-activation potency and response to anti-TNF-α therapy in Crohn's disease.

Authors:  Hanne Rintamäki; Taina Sipponen; Harri-M Salo; Outi Vaarala; Kaija-Leena Kolho
Journal:  World J Gastroenterol       Date:  2010-12-14       Impact factor: 5.742

3.  Autoimmunity to glutamic acid decarboxylase in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).

Authors:  P Klemetti; P Björses; T Tuomi; J Perheentupa; J Partanen; N Rautonen; A Hinkkanen; J Ilonen; O Vaarala
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

4.  Immunomodulation by roquinimex decreases the expression of IL-23 (p19) mRNA in the brains of herpes simplex virus type 1 infected BALB/c mice.

Authors:  J Peltoniemi; E K Broberg; A Halenius; N Setala; J-P Eralinna; A A Salmi; M Roytta; V Hukkanen
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

5.  Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.

Authors:  Eeva K Broberg; Jutta Peltoniemi; Michaela Nygårdas; Tero Vahlberg; Matias Röyttä; Veijo Hukkanen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

6.  Role of Programmed Cell Death Protein-1 and Lymphocyte Specific Protein Tyrosine Kinase in the Aryl Hydrocarbon Receptor- Mediated Impairment of the IgM Response in Human CD5+ Innate-Like B Cells.

Authors:  Jiajun Zhou; Lance K Blevins; Robert B Crawford; Norbert E Kaminski
Journal:  Front Immunol       Date:  2022-04-26       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.